Lipopolysaccharide inhibits TNF-induced apoptosis: Role of nuclear factor-κB activation and reactive oxygen intermediates

Journal of Immunology

Volumn 162, Issue 3, 1999, Pages 1510-1518

  Manna, Sunil K ^a   Aggarwal, Bharat B ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DAUNORUBICIN; DOXORUBICIN; LIPOPOLYSACCHARIDE; OKADAIC ACID; PACLITAXEL; POLYMYXIN B; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR; VINCRISTINE;

APOPTOSIS; ARTICLE; CELL FUNCTION; CELL LINE; CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS;

APOPTOSIS; BASE SEQUENCE; BIOLOGICAL TRANSPORT, ACTIVE; CASPASE 3; CASPASES; CELL LINE; DNA-BINDING PROTEINS; ENZYME ACTIVATION; GRAM-NEGATIVE BACTERIA; HUMANS; I-KAPPA B PROTEINS; LIPOPOLYSACCHARIDES; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; REACTIVE OXYGEN SPECIES; TRANSCRIPTION FACTOR RELA; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033082465     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Carswell, E. A., L. J. Old, R. L. Kassel, S. Green, N. Fiore, and B. Williamson. 1975. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72:3666.
2. Goeddel, D. V., B. B. Aggarwal, P. W. Gray, D. W. Leung, G. E. Nedwin, M. A. Palladino, J. S. Patton, D. Pennica, H. M. Shepard, B. J. Sugarman et al. 1986. Tumor necrosis factors: gene structure and biological activities. Cold Spring Harbor Symp. Quant. Biol. 51:597.
3. Morrison, D. C., and J. L. Ryan. 1987. Endotoxin and disease mechanism. Annu. Rev. Med. 38:417.
4. Haziot, A., S. Chen, E. Ferrero, M. G. Low, R. Silber, and S. M. Goyert. 1988. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J. Immunol. 141:547.
5. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431.
6. Hailman, E., H. S. Lichenstein, M. M. Wurfel, D. S. Miller, D. A. Johnson, M. Kelley, L. A. Busse, M. M. Zukowski, and S. D. Wright. 1994. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med. 179:269.
7. Haziot, A., E. Ferrero, F. Kontgen, N. Hijiya, S. Yamamoto, J. Silve, C. L. Stewan, and S. M. Goyert. 1996. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 4:407.
8. Henricson, B. E., W. R. Benjamin, and S. N. Vogel. 1990. Differential cytokine induction by doses of lipopolysaccharide and monophosphoryl lipid A that result in equivalent early endotoxin tolerance. Infect. Immun. 58:2429.
9. Aggarwal, B. B., and K. Natarajan. 1996. Tumor necrosis factors: developments during last decade. Eur. Cytokine Netw. 7:93.
10. Haimovitz-Friedman, A., C. Cordon-Cardo, S. Bayoumy, M. Garzotto, M. McLoughlin, R. Gallily, C. K. Edwards III, E. H. Schuchman, Z. Fuks, and R. Kolesnick. 1997. Lipopolysaccharide induces disseminated endothelial apoplosis requiring ceramide generation. J. Exp. Med. 186:1831.
11. Wright, S. D., and R. N. Kolesnick. 1995. Does endotoxin stimulate cells by mimicking ceramide? Immunol. Today 16:297.
12. Joseph, C. K., S. D. Wright, W. G. Bornmann, J. T. Randolph, E. R. Kumar, R. Bittman, J. Liu, and R. N. Kolesnick. 1994. Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells. J. Biol. Chem. 269:17606.
13. Schumann, R. R., C. Belka, D. Reuter, N. Lamping, C. J. Kirschning, J. R. Weber, and D. Pfeil. 1998. Lipopolysaccharide activates caspase-1 (interleukin-1-converting enzyme) in cultured monocytic and endothelial cells. Blood 91:577.
14. Swantek, J. L., M. H. Cobb, and T. D. Geppert. 1997. Jun N-terminal kinase/ stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor a (TNF-α) translation: glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK. Mol. Cell. Biol. 17:6274.
15. Westwick, J., C. Weitzel, A. Minden, M. Karin, and D. A. Brenner. 1994. Tumor necrosis factor-α stimulates AP-1 through prolonged activation of the c-jun kinase. J. Biol. Chem. 269:26396.
16. Baeuerle, P. A., and V. R. Baichwal. 1997. NF-κB as a frequent target for immunosuppressive and ami-inflammatory molecules. Adv. Immunoi. 65:111.
17. Thompson, J. E., R. J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 80:573.
18. Chaturvedi, M. M., R. La Pushin, and B. B. Aggarwal. 1994. Tumor necrosis factor and lymphotoxin: qualitative and quantitative differences in the mediation of early and late cellular response. J. Biol. Chem. 269:14575.
19. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffer. 1989. Rapid detection of octamer binding proteins with mini-extracts, prepared from a small number of cells. Nucleic Acids Res. 17:6419.
20. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
21. Singh, S., and B. B. Aggarwal. 1995. Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-κB. J. Biol. Chem. 270:10611.
22. Manna, S. K., H. J. Zhang, T. Yan, L. W. Oberley, and B. B. Aggarwal. 1998. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-κB and activated protein-1. J. Biol. Chem. 273:13245.
23. Giri, D. K., and B. B. Aggarwal. 1998. Constitutive activation of NF-κB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. J. Biol. Chem. 273:14008.
24. Tewari, M., L. T. Quan, K. O'Rourke, S. Desnoyers, Z. Zeng, D. R. Beidler, C. G. Poirier, G. S. Salvesen, and V. M. Dixit. 1995. Yama/CPP32 β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81:801.
25. Schreck, R., B. Meier, D. N. Mannel, W. Droge, and P. A. Baeuerle. 1992. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med. 175:1181.
26. Srimal, S., N. Surolia, S. Balasubramanian, and A. Surolia. 1996. Titration calorimetric studies to elucidate the specificity of the interactions of polymyxin B with lipopolysaccharides and lipid A. Biochem. J. 315:679.
27. Medvedev, A. E., T. Flo, R. R. Ingalls, D. T. Golenbock, G. Teti, S. N. Vogel, and T. Espevik. 1998. Involvement of CD14 and complement receptors CR3 and CR4 in nuclear factor-κB activation and TNF production induced by lipopolysaccharide and group B streptococcal cell walls. J. Immunol. 160:4535.
28. Wang, C. Y., M. W. Mayo, and A. S. Baldwin. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274:784.
29. Beg, A. A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782.
30. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787.
31. Liu, Z. G., H. Hsu, D. V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87:565.
32. Chu, Z. L., T. A. McKinsey, L. Liu, J. J. Gentry, M. H. Malim, and D. W. Ballard. 1997. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc. Natl. Acad. Sci. USA 94:10057.
33. Cai, Z., M. Korner, N. Tarantino, and S. Chouaib. 1997. IκBα overexpression in human breast carcinoma MCF7 cells inhibits nuclear factor-κB activation but not tumor necrosis factor-α-induced apoptosis. J. Biol. Chem. 272:96.
34. Guo, Y. L., K. Baysal, B. Kang, L. J. Yang, and J. R. Williamson. 1998. Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-α in rat mesangial cells. J. Biol. Chem. 273:4027.
35. Jänicke, R. U., M. L. Sprengart, M. R. Wati, and A. G. Porter. 1998. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273:9357.
36. Laherty, C. D., N. D. Perkins, and V. M. Dixit. 1993. Human T cell leukemia virus type I Tax and phorbol 12-myristate 13-acetate induce expression of the A20 zinc finger protein by distinct mechanisms involving nuclear factor κB. J. Biol. Chem. 268:5032.
37. Tewari, M., F. W. Wolf, M. F. Seldin, K. S. O'Shea, V. M. Dixit, and L. A. Turka. 1995. Lymphoid expression and regulation of A20, an inhibitor of programmed cell death. J. Immunol. 154:1699.
38. Shu, H. B., M. Takeuchi, and D. V. Goeddel. 1996. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor I signaling complex. Proc. Natl. Acad. Sci. USA 93:13973.
39. Sanna, M. G., C. S. Duckett, B. W. M. Richter, C. B. Thompson, and R. J. Ulevitch. 1998. Selective activation of JNK1 is necessary for anti-apoptotic activity of hILP. Proc. Natl. Acad. Sci. USA 95:6015.
40. Roulston, A., C. Reinhard, P. Amiri, and L. T. Williams. 1998. Early activation of c-Jun N-terminal kinase and p38 kinase regulates cell survival in response to tumor necrosis factor-α. J. Biol. Chem. 273:10232.
41. Guo, Y. L., B. Kang, and J. R. Williamson. 1998. Inhibition of the expression of mitogen-activaled protein phosphatase-1 potentiates apoptosis induced by tumor necrosis factor-α in rat mesangial cells. J. Biol. Chem. 273:10362.
42. Lee, J. C., and P. R. Young. 1996. Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J. Leukocyte Biol. 59:152.
43. Schwenger, P., D. Alpert, E. Y. Skolnik, and J. Vilcek. 1998. Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IκBα phosphorylation and degradation. Mol. Cell. Biol. 18:78.
44. Schwenger, P., P. Bellosta, I. Vietor, C. Basilico, E. Y. Skolnik, and J. Vilcek. 1997. Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Prof. Natl. Acad. Sci. USA 94:2869.
45. Darnay, B. G., and B. B. Aggarwal. 1997. Early events in TNF signaling: a story of associations and dissociations. J. Leukocyte Biol. 61:559.
46. Haldar, S., J. Chintapalli, and C. M. Croce. 1996. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res. 56:1253.
47. Haldar, S., N. Jena, and C. M. Croce. 1995. Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA 92:4507.
48. Haldar, S., A. Basu, and C. M. Croce. 1997. Bcl2 is the guardian of microtubule integrity. Cancer Res. 57:229.
49. Jones, P. L., D. Ping, and J. M. Boss. 1997. Tumor necrosis factor α and interleukin-1β regulate the murine manganese superoxide dismutase gene through a complex intronic enhancer involving C/EBP-β and NF-κB. Mol. Cell. Biol. 17: 6970.
50. Shattuck-Brandt, R. L., and A. Richmond. 1997. Enhanced degradation of IκBα contributes to endogenous activation of NF-κB in Hs294T melanoma cells. Cancer Res. 57:3032.
51. Nakshatri, H., P. Bhat-Nakshatri, D. A. Martin, R. J. Goulet Jr., and G. W. Sledge Jr. 1997. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol. 17:3629.
52. Gilmore, T. D., M. Koedood, K. A. Piffat, and D. W. White. 1996. Rel/NF-κB/ IκB proteins and cancer. Oncogene 13:1367.
53. Bours, V., E. Dejardin, F. Goujon-Letawe, M. P. Merville, and V. Castronovo. 1994. The NF-κB transcription factor and cancer: high expression of NF-κB- and IκB-related proteins in tumor cell lines. Biochem. Pharmacol. 47:145.